India · Delayed Price · Currency is INR Ganga Pharmaceuticals Statistics
Total Valuation
BOM:539680 has a market cap or net worth of INR 73.89 million. The enterprise value is 84.21 million.
| Market Cap | 73.89M |
| Enterprise Value | 84.21M |
Important Dates
The last earnings date was Monday, November 2, 2026.
| Earnings Date | Nov 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:539680 has 5.91 million shares outstanding. The number of shares has decreased by -70.74% in one year.
| Current Share Class | 5.91M |
| Shares Outstanding | 5.91M |
| Shares Change (YoY) | -70.74% |
| Shares Change (QoQ) | -9.31% |
| Owned by Insiders (%) | 62.83% |
| Owned by Institutions (%) | n/a |
| Float | 1.10M |
Valuation Ratios
The trailing PE ratio is 41.67.
| PE Ratio | 41.67 |
| Forward PE | n/a |
| PS Ratio | 2.62 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 129.36 |
| EV / Sales | 2.99 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.72, with a Debt / Equity ratio of 0.15.
| Current Ratio | 5.72 |
| Quick Ratio | 0.79 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.73 |
Financial Efficiency
Return on equity (ROE) is 0.78% and return on invested capital (ROIC) is -0.61%.
| Return on Equity (ROE) | 0.78% |
| Return on Assets (ROA) | -0.51% |
| Return on Invested Capital (ROIC) | -0.61% |
| Return on Capital Employed (ROCE) | -0.96% |
| Weighted Average Cost of Capital (WACC) | 6.39% |
| Revenue Per Employee | 1.66M |
| Profits Per Employee | 38,294 |
| Employee Count | 17 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.21 |
Taxes
In the past 12 months, BOM:539680 has paid 256,000 in taxes.
| Income Tax | 256,000 |
| Effective Tax Rate | 28.22% |
Stock Price Statistics
The stock price has decreased by -14.38% in the last 52 weeks. The beta is 0.38, so BOM:539680's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -14.38% |
| 50-Day Moving Average | 18.26 |
| 200-Day Moving Average | 12.08 |
| Relative Strength Index (RSI) | 45.10 |
| Average Volume (20 Days) | 18,400 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539680 had revenue of INR 28.21 million and earned 651,000 in profits. Earnings per share was 0.30.
| Revenue | 28.21M |
| Gross Profit | 14.10M |
| Operating Income | -815,000 |
| Pretax Income | 907,000 |
| Net Income | 651,000 |
| EBITDA | -229,000 |
| EBIT | -815,000 |
| Earnings Per Share (EPS) | 0.30 |
Balance Sheet
The company has 217,000 in cash and 12.26 million in debt, with a net cash position of -12.04 million or -2.04 per share.
| Cash & Cash Equivalents | 217,000 |
| Total Debt | 12.26M |
| Net Cash | -12.04M |
| Net Cash Per Share | -2.04 |
| Equity (Book Value) | 83.31M |
| Book Value Per Share | 13.44 |
| Working Capital | 64.07M |
Cash Flow
In the last 12 months, operating cash flow was -5.29 million and capital expenditures -277,000, giving a free cash flow of -5.57 million.
| Operating Cash Flow | -5.29M |
| Capital Expenditures | -277,000 |
| Depreciation & Amortization | 586,000 |
| Net Borrowing | -1.60M |
| Free Cash Flow | -5.57M |
| FCF Per Share | -0.94 |
Margins
Gross margin is 49.97%, with operating and profit margins of -2.89% and 2.31%.
| Gross Margin | 49.97% |
| Operating Margin | -2.89% |
| Pretax Margin | 3.22% |
| Profit Margin | 2.31% |
| EBITDA Margin | -0.81% |
| EBIT Margin | -2.89% |
| FCF Margin | n/a |
Dividends & Yields
BOM:539680 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 70.74% |
| Shareholder Yield | 70.74% |
| Earnings Yield | 2.40% |
| FCF Yield | -7.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |